Condition: AORTIC VALVE DISEASES · Thromboembolism · Sponsor: Joon Bum Kim
This study evaluates the long-term anticoagulation with oral factor Xa inhibitor versus vitamin K antagonist in patients receiving a mechanical aortic valve replacement.
This description comes directly from the study's public registry record.
Jung-hee Ham, RN · 82230104728 · cvcrc5@amc.seoul.kr
Always discuss trial participation with your own doctor first.
| Buchen Sejong Hospital | Bucheon-si, South Korea | Recruiting |
| Dong-A University Hospital | Busan, South Korea | Recruiting |
| Keimyung University Dongsan Hospital | Daegu, South Korea | Recruiting |
| GangNeung Asan Hospital | Gangneung, South Korea | Recruiting |
| Chonnam National University Hospital | Gwangju, South Korea | Recruiting |
| Seoul National University Bundang Hospital | Seongnam, South Korea | Recruiting |
| Asan Medical Center | Seoul, South Korea | Recruiting |
| Korea University Anam Hospital | Seoul, South Korea | Recruiting |
| Samsung Medical Center | Seoul, South Korea | Recruiting |
| Seoul National University Hospital | Seoul, South Korea | Recruiting |
| Severance Hospital | Seoul, South Korea | Not Yet Recruiting |
| Ajou University Hospital | Suwon, South Korea | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04258488